Lung cancer				Gallbladder cancer
	1-yr survival (%; 95% CI)	3-yr survival (%;95%CI)	5-yr survival (%;95%CI)	P-value†	1-yr survival (%; 95% CI)	3-yr survival (%; 95% CI)	5-yr survival (%; 95% CI)	P-value†
Age at diagnosis					Age at diagnosis
30-40 years	40.0 (16.5-62.8)	20.0 (4.9-42.4)	Nil	0.0343	29.2 (12.9-47.6)	8.3 (1.4-23.3)	Nil	0.8122
41-50 years	56.7 (37.3-72.1)	17.4 (6.1-33.6)	8.7 (0.9-28.4)		32.8 (21.5-44.6)	Nil	Nil
51-69 years	31.5 (23.8-39.6)	7.3 (3.4-13.1)	Nil		26.6 (18.1-35.8)	7.9 (3.5-14.7)	Nil
Sex:					Sex:
Men	35.1 (27.5- 42.8)	9.3 (5.1- 15.2)	1.9 (0.2-8.1)	0.2438	18.2 (9.4-29.3)	6.4 (1.7-15.3)	Nil	0.2367
Women	44.4 (25.6-61.7)	14.8 (4.7-30.4)	Nil		33.9 (25.7-42.2)	5.3 (2.1-10.7)	Nil
Education:					Education
No formal education	42.0 (283-55.1)	5.4 (1.1-15.1)	Nil	0.5564	32.9 (23.2-42.9)	4.2 (1.0-11.4)	Nil	0.3121
Up to 4 years	30.3 (15.9-46.1)	17.7 (6.9-32.5)	17.7 (6.9-32.5)		30.8 (14.6-48.5)	15.4 (4.8-31.5)	Nil
5-12 years	31.4 (19.3-44.2)	9.1 (3.1-19.2)	Nil		22.5 (11.1-36.3)	Nil	Nil
Graduation/ above	56.2 (29.5-76.2)	Nil	Nil		27.3 (6.5-53.9)	9.1 (0.5-33.5)	Nil
Clinical extent					Clinical extent
Localised/direct extension	40.0 (26.5-53.1)	9.7 (3.1-21.0)	Nil	0.3090	48.9 (34.1-62.2)	17.9 (8.3-30.4)	Nil	0.0028
Regional nodes extension	36.4 (22.6-50.3)	13.3 (5.0-25.6)	Nil		41.2 (18.6-62.6)	Nil	Nil
Metastasis/advanced/ recurrence	34.2 (23.6-45.1)	Nil	Nil		20.0 (13.0-28.1)	0.9 (0.08-4.5)	Nil
Histology					NOT APPLICABLE
Non-small cell	43.2 (33.1-58.8)	11.4 (5.5-19.6)	Nil	0.3818
Small cell	27.3 (15.2-40.8)	6.8 (1.8-16.7)	Nil
Others	33.3 (18.2-49.3)	12.1 (3.8-25.5)	3.0 (0.2-13.3)